ATE419003T1 - Mycobakterielle proteinantigene für krebstherapie und impfung - Google Patents

Mycobakterielle proteinantigene für krebstherapie und impfung

Info

Publication number
ATE419003T1
ATE419003T1 AT03019169T AT03019169T ATE419003T1 AT E419003 T1 ATE419003 T1 AT E419003T1 AT 03019169 T AT03019169 T AT 03019169T AT 03019169 T AT03019169 T AT 03019169T AT E419003 T1 ATE419003 T1 AT E419003T1
Authority
AT
Austria
Prior art keywords
vaccination
protein antigens
cancer therapy
mycobacterial protein
protein
Prior art date
Application number
AT03019169T
Other languages
English (en)
Inventor
Mahavir Singh
Andreas Boehle
Christian Saenger
Sven Brandau
Original Assignee
Axenoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axenoll Ag filed Critical Axenoll Ag
Application granted granted Critical
Publication of ATE419003T1 publication Critical patent/ATE419003T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001176—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03019169T 2003-08-22 2003-08-22 Mycobakterielle proteinantigene für krebstherapie und impfung ATE419003T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03019169A EP1508338B1 (de) 2003-08-22 2003-08-22 Mycobakterielle Proteinantigene für Krebstherapie und Impfung

Publications (1)

Publication Number Publication Date
ATE419003T1 true ATE419003T1 (de) 2009-01-15

Family

ID=34042896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03019169T ATE419003T1 (de) 2003-08-22 2003-08-22 Mycobakterielle proteinantigene für krebstherapie und impfung

Country Status (4)

Country Link
EP (1) EP1508338B1 (de)
AT (1) ATE419003T1 (de)
DE (1) DE60325586D1 (de)
ES (1) ES2320538T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2382825C2 (ru) * 2007-11-19 2010-02-27 Закрытое акционерное общество "Новокраматорский машиностроительный завод" Роликозакалочная машина
RU2382087C2 (ru) * 2007-12-21 2010-02-20 Закрытое акционерное общество "Новокраматорский машиностроительный завод" Устройство для термообработки горячекатаного листа
EP2821221A1 (de) * 2013-07-04 2015-01-07 PetroplastVinora AG Peelfähige Folie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517839B1 (en) * 1997-07-18 2003-02-11 The Regents Of The University Of California Methods for inducing interleukin-12 and a type1/Th1 T-cell response
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants

Also Published As

Publication number Publication date
DE60325586D1 (de) 2009-02-12
EP1508338B1 (de) 2008-12-31
EP1508338A1 (de) 2005-02-23
ES2320538T3 (es) 2009-05-25

Similar Documents

Publication Publication Date Title
ATE440107T1 (de) Tumorassoziierte peptide, die hla klasse i oder ii-moleküle binden, und anti-tumor impfstoffe
MX2007003402A (es) Composicion inmunogena para su uso en vacunacion contra estafilococos.
ATE388164T1 (de) Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
NO20015073L (no) Vaksiner
WO2006081007A3 (en) Use of flagellin in tumor immunotherapy
ATE421533T1 (de) Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden
ATE546153T1 (de) Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen
WO2005007673A3 (en) Immunogenic peptides
DK1350839T3 (da) Identificering af de virulensassocierede regioner RD1 og RD5, hvilket muliggør udvikling af forbedrede vacciner af M. bovis BCG og M. microti
EA200900795A1 (ru) Вакцина
DE60325586D1 (de) Mycobakterielle Proteinantigene für Krebstherapie und Impfung
CR9097A (es) Formulaciones inmunoterapeuticas para la induccion de autoanticuerpos bloqueadores de la union de interleucina-2 a su receptor. su uso en tratamiento del cancer
AR022662A1 (es) Acidos nucleicos y proteinas del gen mhp3 de mycoplasma hyopneumoniae y sus usos
ATE525401T1 (de) Vom tumorantigen 5t4 abgeleitete mhc-klasse-i- und ii-peptidantigene
UY29216A1 (es) Formulaciones inmunoterapeúticas para la inducción de autoanticuerpos bloqueadores de la unión de interleucina-2 a su receptor. su uso en el tratamiento del cáncer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1508338

Country of ref document: EP